Another study showed that SUMOylation of TFAP2A is necessary to maintain basal breast cancer phenotypes (49), suggesting that there may be a mutual regulatory relationship between TFAP2A and the SUMO pathway. This evidence concerns the gene TFAP2A and breast cancer.